I believe that IPV vaccine is avaliable with VVM 14 and 30. VVM 14 color changes faster, can we use IPV with VVM 30 for immunization program? Any price difference between VVM 14 and 30? Can someone help to respond?...

Dear viewers We wish to share our very short study finding with the TechNet viewers for further input and mutual sharing of experiences for the global benefit of closing the imuunization gap. Introduction of a newer vaccine or any change in vaccination policy provides an opportunity to train / reo...

Thirty countries have now introduced IPV vaccine as part of objective 2 of the Polio Eradication and Endgame Strategic Plan. In August, the second of the polio endemic countries, Pakistan, introduced IPV nationally. There are now 30 countries that have introduced the vaccine. Nigeria, the other ende...

Well-planned, adequately funded communications affect the success of immunization services and are particularly needed to achieve vaccination coverage goals and maintain trust in vaccines. A communications plan and its activities – such as media briefings, stakeholder engagement, and social mobil...

The January 2015 edition of the IVAC VIMS Report on Global Vaccine Introduction is now available at http://www.jhsph.edu/research/centers-and-institutes/ivac/vims/IVAC-VIMS-Report-2015-Jan.pdf New in the January edition is the addition of an inactivated polio vaccine (IPV) section in the report....

Dear Friends, I must congratulate the GAVI board for taking a decision on introducing IPV. I hope the IPV would be introduced through cost effective intra-dermal method by enhancing its antigenic content and also through cost effective disposable syringe and needle method. Also the decision for inc...

Dear Sir,Based on the PATH report, we must immediately demand from DCGI office or GOI for use of IPV through Intradermal Route as well, otherwise people would be cheated as they have been with Rabies vaccine. Though I disagree with the report on one point that is a device is required for effective d...

Many thanks to Emily Griswold, PATH, for sharing this document with TechNet21 readers.  PATH and Working in Tandem, Ltd., recently released a report entitled “Improving the affordability of inactivated poliovirus vaccines (IPV) for use in low- and middle-income countries: an economic analysis ...

POST 01096E : IPV EFFICACY 23 May 2007 _______________________________________ In the perspective of polio eradication and cessation of OPV vaccination, you will be interested in the following article : "Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba" by The Cuba I...